Literature DB >> 16884661

Angiotensin-receptor blockers for prehypertension.

Dan Carl, Domenic A Sica.   

Abstract

Entities:  

Year:  2006        PMID： 16884661     DOI： 10.1007/s11906-006-0069-9

Source DB:  PubMed          Journal:  Curr Hypertens Rep        ISSN： 1522-6417            Impact factor:   5.369


× No keyword cloud information.
  5 in total

1.  Assessment of frequency of progression to hypertension in non-hypertensive participants in the Framingham Heart Study: a cohort study.

Authors:  R S Vasan; M G Larson; E P Leip; W B Kannel; D Levy
Journal:  Lancet       Date:  2001-11-17       Impact factor: 79.321

2.  Impact of high-normal blood pressure on the risk of cardiovascular disease.

Authors:  R S Vasan; M G Larson; E P Leip; J C Evans; C J O'Donnell; W B Kannel; D Levy
Journal:  N Engl J Med       Date:  2001-11-01       Impact factor: 91.245

3.  Effects of comprehensive lifestyle modification on diet, weight, physical fitness, and blood pressure control: 18-month results of a randomized trial.

Authors:  Patricia J Elmer; Eva Obarzanek; William M Vollmer; Denise Simons-Morton; Victor J Stevens; Deborah Rohm Young; Pao-Hwa Lin; Catherine Champagne; David W Harsha; Laura P Svetkey; Jamy Ard; Phillip J Brantley; Michael A Proschan; Thomas P Erlinger; Lawrence J Appel
Journal:  Ann Intern Med       Date:  2006-04-04       Impact factor: 25.391

4.  Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure.

Authors:  Aram V Chobanian; George L Bakris; Henry R Black; William C Cushman; Lee A Green; Joseph L Izzo; Daniel W Jones; Barry J Materson; Suzanne Oparil; Jackson T Wright; Edward J Roccella
Journal:  Hypertension       Date:  2003-12-01       Impact factor: 10.190

5.  Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies.

Authors:  Sarah Lewington; Robert Clarke; Nawab Qizilbash; Richard Peto; Rory Collins
Journal:  Lancet       Date:  2002-12-14       Impact factor: 79.321
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.